Oxford Asset Management’s Idexx Laboratories IDXX Stock Holding History

Oxford Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-307	Closed	-$208K	–	607
2025 Q4	$208K	Buy	+307	New	+$209K	0.08%	367
2020 Q1	–	Sell	-28,103	Closed	-$7.34M	–	723
2019 Q4	$7.34M	Buy	+28,103	New	+$7.41M	0.2%	113
2019 Q3	–	Sell	-6,700	Closed	-$1.84M	–	1831
2019 Q2	$1.84M	Buy	6,700 +2,253	+51%	+$555K	0.04%	678
2019 Q1	$994K	Buy	+4,447	New	+$918K	0.02%	933
2018 Q4	–	Sell	-17,143	Closed	-$4.26M	–	1920
2018 Q3	$4.26M	Sell	17,143 -34,812	-67%	-$8.45M	0.09%	274
2018 Q2	$11.3M	Buy	51,955 +5,460	+12%	+$1.13M	0.22%	71
2018 Q1	$8.9M	Sell	46,495 -11,486	-20%	-$2.12M	0.19%	89
2017 Q4	$9.21M	Buy	57,981 +36,530	+170%	+$5.75M	0.2%	78
2017 Q3	$3.32M	Buy	21,451 +13,364	+165%	+$2.11M	0.06%	364
2017 Q2	$1.3M	Sell	8,087 -11,704	-59%	-$1.9M	0.03%	798
2017 Q1	$3.06M	Sell	19,791 -14,282	-42%	-$1.97M	0.07%	281
2016 Q4	$4M	Buy	34,073 +11,540	+51%	+$1.32M	0.14%	139
2016 Q3	$2.54M	Buy	+22,533	New	+$2.37M	0.08%	355
2015 Q1	–	Sell	-6,264	Closed	-$469K	–	701
2014 Q4	$469K	Buy	+6,264	New	+$439K	0.01%	566

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Oxford Asset Management's IDXX Position: Q1 2026 in Review

Oxford Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 307 shares — an estimated $208K sold.

Oxford Asset Management first reported a position in IDXX in Q4 2014 and held it in 14 quarters. The position peaked at $11.3M in Q2 2018. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Oxford Asset Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Oxford Asset Management sold 307 Idexx Laboratories shares in Q1 2026, an estimated $208K.
Oxford Asset Management first reported a position in Idexx Laboratories in Q4 2014 and held it in 14 quarters.
Oxford Asset Management's Idexx Laboratories position peaked at $11.3M in Q2 2018.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Oxford Asset Management's 13F filing for Q1 2026, filed 15 May 2026.